Viral Growth - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

Viral Growth

Description:

Nucleic acid (DNA or RNA not both! ... Circularization of the phage chromosome. Cohesive ends. Ligase. Closed Circle. Cohesive Ends ... – PowerPoint PPT presentation

Number of Views:127
Avg rating:3.0/5.0
Slides: 26
Provided by: paulbr8
Category:

less

Transcript and Presenter's Notes

Title: Viral Growth


1
Viral Growth
  • Dr Paul Brown
  • paul.brown_at_uwimona.edu.jm
  • BC10M Introductory Biochemistry
  • Lecture 7

2
Characteristics of Viruses
  • Non-living agents that infect all life forms
    (Bacteriophages, plant viruses, and animal
    viruses)
  • One virus particle virion (size 10 500 nm)
  • Virus architecture
  • Nucleic acid (DNA or RNA not both!)
  • Protein coat capsid of various shapes
    (isometric, helical, complex)
  • Naked virions vs. enveloped viruses
  • Genome ss-/ds-RNA, ss-/dsDNA linear or circular

3
Methods of Study
  • Much more expensive and difficult to study animal
    viruses than bacteriophages
  • Cultivation in host cells
  • Living animal
  • Embryonated chicken eggs
  • Cell or tissue culture ( in vitro)

4
Methods of Study cont Quantitation
  • Plaque assay (useful for infective and lytic
    viruses)
  • Virion counting with EM
  • Quantal assay (ID50 or LD50)
  • Haemagglutination (e.g.influenza virus)

5
Culturing viruses requires an appropriate host
cell. In this example a bacteriophage is grown
using bacterial cells as host cells. Animal or
plant viruses can be grown in tissue culture.
6
Plaques in a lawn of bacterial cells caused by
viruses lysing bacterial cells.
7
Replication Cycle - Overview
  • Obligate intracellular parasites using host cell
    machinery
  • Very limited number of genes encode proteins for
  • Capsid formation
  • Viral nucleic acid replication
  • Movement of virus into and out of cell
  • Kill or live in harmony within the host cell
    Outside the cell, viruses are inert

Fig 13.3
Size comparison(see also Table 13.1)
8
Bacteriophage (Phage)
  • Obligate intracellular parasites that multiply
    inside bacteria by making use of some or all of
    the host biosynthetic machinery
  • Significance
  • Models for animal cell viruses
  • Gene transfer in bacteria (transduction)
  • Medical applications
  • Identification of bacteria - phage typing
  • Treatment and prophylaxis???
  • Examples T4 and Lambda (?)

9
Composition and Structure
  • Composition
  • Nucleic acid
  • Genome size
  • Modified bases
  • Protein
  • Protection
  • Infection
  • Structure (T4)
  • Size
  • Head or capsid
  • Tail

10
Infection of Host Cells
  • Irreversible attachment
  • Adsorption
  • LPS for T4
  • Sheath Contraction
  • Nucleic acid
  • injection

11
Lytic Bacteriophage
  • Lytic or virulent phage Phage that can only
    multiply within bacteria and kill the cell by
    lysis. (e.g., T4)

12
One-step growth curve of a lyticbacteriophage
13
Lytic Phage Multiplication Cycle
  • Eclipse
  • Early genes
  • Phage DNA synthesis
  • Late genes
  • Intracellular accumulation
  • Lysis and Release

14
Time course of events occurring during one-step
growth curve of bacteriophage T4.
15
Lysogenic Bacteriophage
  • Lysogenic or temperate phage Phage that can
    either multiply via the lytic cycle or enter a
    quiescent state in the bacterial cell. (e.g., ?)
  • Expression of most phage genes repressed
  • Prophage
  • Lysogen

16
Lysogenic Phage
  • DNA integrates into host chromosome
  • Phage DNA Prophage
  • Infected bacterial cell lysogenic cell or
    lysogen
  • Prophage state can be indefinite
  • Lysogenic conversion confers new properties onto
    host cells (e.g. toxin production of S. pyogenes
    scarlet fever)
  • Phage induction converts lysogenic to lytic state

17
Replication cycle in a lysogenic bacteriophage
18
Events Leading to Lysogeny
  • Circularization of the phage chromosome
  • Cohesive ends

19
Events Leading to Lysogeny
  • Site-specific recombination
  • Phage coded enzyme
  • Repression of the phage genome
  • Repressor protein
  • Specific
  • Immunity to superinfection

20
Termination of Lysogeny
  • Induction
  • Adverse conditions
  • Role of proteases
  • recA protein
  • Destruction of repressor
  • Gene expression
  • Excision
  • Lytic growth

21
Lytic vs Lysogenic Cycle?
  • Role of repressor
  • Role of cro gene product
  • Role of proteases

22
Significance of Lysogeny
  • Model for animal virus transformation
  • Lysogenic or phage conversion
  • Definition A change in the phenotype of a
    bacterial cell as a consequence of lysogeny
  • Modification of Salmonella O antigen
  • Toxin production by Corynebacterium diphtheriae

23
Host Range of Phages
  • Phage host cell interaction usually very specific
  • Limiting factors for host range
  • Phage has to bind to bacterial surface receptors
  • Bacterial surface receptors mutate ? resistant
    cell
  • Lysogenic conversion changes surface receptors
    and protects host
  • Restriction modification system of host cell

24
Medical Applications of Phage
  • I strongly believe phage could become an
    effective antibacterial tool - Carl Merril,
    Chief of the Laboratory of Biochemical Genetics,
    National Institute of Mental Health, NIH.
  • It might be another string on the bow, such that
    when (conventional antibiotics) fail, heres
    something that has a chance of working. But its
    not going to be a panacea - Joshua Lederberg,
    Sackler Foundation Scholar at The Rockefeller
    University

Reassessment of Medicinal Phage Spurs Companies
to Study Therapeutic Uses American Society for
Microbiology News 64620-623, 1998
25
Medical Applications of Phage
  • Exponential Biotherapies (Rockville, MD)
  • Vancomycin resistant Enterococcus faecium and
    Streptococcus pneumoniae
  • Phage Therapeutics (Bothell, WA)
  • Staphylococcus aureus and Staphylococcus
    epidermidis
  • Intralytix, Inc. (Baltimore, MD)
  • Salmonella in meat and poultry
  • Biopharm Ltd. (Tblisi, Georgia)
  • Infections associated with burns
  • University of Idaho
  • Escherichia coli O157H7 in cattle

Reassessment of Medicinal Phage Spurs Companies
to Study Therapeutic Uses. American Society for
Microbiology News 64620-623, 1998. Phages eyed
as agents to protect against harmful E. coli.
American Society for Microbiology News
65666-667, 1999.
The End
Write a Comment
User Comments (0)
About PowerShow.com